Send your question to our producers before they go on.
All upcoming interviews →
Your question goes privately to our producers — it won’t be posted publicly. We can’t promise every question makes air, but we read them all.
Your question goes privately to our producers — it won’t be posted publicly. We can’t promise every question makes air, but we read them all.
Your question goes privately to our producers — it won’t be posted publicly. We can’t promise every question makes air, but we read them all.
Your question goes privately to our producers — it won’t be posted publicly. We can’t promise every question makes air, but we read them all.
Your question goes privately to our producers — it won’t be posted publicly. We can’t promise every question makes air, but we read them all.
Your question goes privately to our producers — it won’t be posted publicly. We can’t promise every question makes air, but we read them all.
The ideas, voices, and stories we’re following beyond the live show.
For a quarter century, the opioid epidemic has defined an era of loss in America. At its worst, it claimed more than 100,000 lives each year. Now that trajectory has begun to change.
Read Now →When Congress returns from the August recess, it will confront a long list of competing priorities. Amid debates over appropriations and other pressing issues, lawmakers should not lose sight of an issue that directly affects millions of Americans living with chronic disease: preserving access to the clinical laboratory testing that helps patients manage their health every day. For people living with diabetes, kidney disease, heart disease, cancer, autoimmune disorders, and countless other chronic conditions, laboratory testing is not optional.
Read Now →Industry and government officials widely believed that American frontier models were six months ahead of Chinese competitors. That lead shrank last month when the China-based Moonshot AI released its new model Kimi K3. This Chinese model is competitive with America’s leading artificial intelligence models by some measures.
Read Now →
All August, Roll Call and 535 are teaming up on the Political Animals podcast for an inside look at the issues shaping Congress. In the third episode, 535 Contributing Host & Analyst Susan Davis joins the Roll Call team to discuss surface transportation reauthorization legislation and other transportation-related issues. Watch the episode now.
Watch Now →
On the record or off. Lawmakers, staffers, lobbyists, journalists — if it belongs on Capitol Hill, we want to hear it.
Thanks for reaching out. We review every pitch and will follow up if we want to pursue the story.
